antisense oligonucleotides (Genta/CVT/Genta Jago)

N/A

Report date: 2025/03/14 20:00:48
NME

Base Information

Drug Nameantisense oligonucleotides (Genta/CVT/Genta Jago)
Drug Alias NameAnticode (Genta/CV Therapeutics/Genta Jago)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclin-dependent kinase inhibitors
TargetsCyclin-dependent kinase
Therapy Area/IndicationsCoronary RestenosisCoronary Artery Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesStanford University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGenta Jago Technologies BVGilead Palo Alto IncGenta Incorporated +[4] 
Active IndicationsN/A
Inactive IndicationsCoronary RestenosisCoronary Artery Disease

Other Information

ATC CodeN/A
Related LinksN/A